Global 0.9% Sodium Chloride Intravenous Infusion Market Growth 2022-2028

0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
The global market for 0.9% Sodium Chloride Intravenous Infusion is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC 0.9% Sodium Chloride Intravenous Infusion market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States 0.9% Sodium Chloride Intravenous Infusion market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe 0.9% Sodium Chloride Intravenous Infusion market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China 0.9% Sodium Chloride Intravenous Infusion market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key 0.9% Sodium Chloride Intravenous Infusion players cover Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical and CR Double-Crane, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global 0.9% Sodium Chloride Intravenous Infusion market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global 0.9% Sodium Chloride Intravenous Infusion market, with both quantitative and qualitative data, to help readers understand how the 0.9% Sodium Chloride Intravenous Infusion market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K L.

Market Segmentation:

The study segments the 0.9% Sodium Chloride Intravenous Infusion market and forecasts the market size by Type (Flexible Bag, Plastic Bottles and Glass Bottle), by Application (Hospitals, Clinics and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Flexible Bag
Plastic Bottles
Glass Bottle
Segmentation by application
Hospitals
Clinics
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
BBraun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical

Chapter Introduction
Chapter 1: Scope of 0.9% Sodium Chloride Intravenous Infusion, Research Methodology, etc.
Chapter 2: Executive Summary, global 0.9% Sodium Chloride Intravenous Infusion market size (sales and revenue) and CAGR, 0.9% Sodium Chloride Intravenous Infusion market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: 0.9% Sodium Chloride Intravenous Infusion sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global 0.9% Sodium Chloride Intravenous Infusion sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global 0.9% Sodium Chloride Intravenous Infusion market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane, BBraun, Otsuka, Cisen Pharmaceutical and Hospira (ICU Medical), etc.
Chapter 14: Research Findings and Conclusion

Please note: The report will take approximately 2 business days to prepare and deliver.